Comparison of the immunogenicity and safety of Euvichol-Plus with Shanchol in healthy Indian adults and children: an open-label, randomised, multicentre, non-inferiority, parallel-group, phase 3 trial.

ABSTRACT:

SUBMITTER: Shah S 

PROVIDER: S-EPMC10709676 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature